Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 1217-1222, July 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodall, C. M.
Right arrow Articles by Tomatis, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodall, C. M.
Right arrow Articles by Tomatis, L.

Tumorigenicity of N-Nitrosohexamethyleneimine1

C. M. Goodall2, W. Lijinsky3 and L. Tomatis4

Division of Oncology, The Chicago Medical School, Chicago, Illinois 60612

A new carcinogen, N-nitrosohexamethyleneimine (N-nitrosoperhydroazepine), was synthesized and given to rats of both sexes. The incidence of mixed malignant liver cell carcinomas and endothelial sarcomas was virtually 100% when the drug was given at 200 mg/liter for 8 weeks, while benign and malignant epitheliomas of the tongue or esophagus occurred in about 30%. When the drug concentration was 50 mg/liter given continuously over the life-span of the animals, the incidence pattern of tumors in liver and upper alimentary tract was reversed. The possible relevance of the types and distribution of these cancers to interpretations of the mechanism of action is discussed.

1 This work was supported by USPHS Contract #43-65-67 from the National Cancer Institute, and by grants from the Cancer Society of New Zealand.

2 Present address: National Cancer Research Laboratories, University of Otago, New Zealand.

3 Recipient of a Research Career Development Award, USPHS.

4 Present address: World Health Organization, 16; Avenue Marechal Foch, 69 Lyon, France.

Received 8/22/67. Accepted 4/ 1/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.